Skip to content

Advertisement

Journal of Venomous Animals and Toxins including Tropical Diseases

What do you think about BMC? Take part in

Call for Papers: Novel hit and lead compounds against neglected protozoan diseases

Edited by Andre G. Tempone and Erika G. Pinto

This collection aims to build bridges between novel hit or lead compounds and new alternative therapies for neglected protozoan diseases (including malaria). We welcome contributions describing the in vitro and/or in vivo activity of antiprotozoan compounds isolated from natural products and synthetic compounds. 

The proposed deadline for submissions is March 20, 2018

Articles

View all articles
View all articles

Institutional affiliation

The Center for the Study of Venoms and Venomous Animals (Cevap) was established in 1989 and became an official São Paulo State University (Unesp) research unit in 1993. Cevap's mission is to provide world class expertise on venomous animals, their toxins and the derivatives. Its objectives include:

  • the extraction of toxins to develop experimental research, immunobiological products and clinical trials
  • to develop biotechnological study of animal toxins
  • administering traditional or long-distance graduate and specialization courses

Sponsor information

We would like to thank our sponsors for their support in funding editorial costs:

     


 

Archival content

A complete electronic archive of articles published between 1995 and 2012 can be found in the SciELO database:

Aims and scope

Journal of Venomous Animals and Toxins including Tropical Diseases (JVATiTD) is an open access interdisciplinary publication, dedicated to research on all aspects of toxins, venomous animals and their derivative products. The journal also welcomes submissions related to tropical diseases with a focus on infectious diseases, parasitology and immunology. Read more about the journal scope.

Editor's quote

"Tropical Diseases and Toxinology are neglected areas in international science. Therefore, we must have research models that are efficient, cheaper and applicable to our patients. At Cevap, we believe that natural toxins comprise fascinating alternative models that are innovating the development of new drugs to treat animal and human diseases."

Dr. Benedito Barraviera is a researcher at the Center for the Study of Venoms and Venomous Animals (Cevap) and full professor of the Department of Tropical Diseases of Botucatu Medical School, both at São Paulo State University (Unesp), Brazil.

Latest Tweets

Advertisement